Patent details

EP3184523 Title: N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE FOR USE IN THE TREATMENT OF A CELL PROLIFERATIVE DISORDER OF THE HEMATOLOGIC SYSTEM

Basic Information

Publication number:
EP3184523
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP161917166
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE FOR USE IN THE TREATMENT OF A CELL PROLIFERATIVE DISORDER OF THE HEMATOLOGIC SYSTEM
French Title of Invention:
BROMHYDRATE DE N-((4,6-DIMÉTHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)MÉTHYL)-5-(ÉTHYL (TÉTRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-MÉTHYL-4'-(MORPHOLINOMÉTHYL)-[L,1'-BIPHÉNYL]-3-CARBOXAMIDE POUR L'UTILISATION DANS LE TRAITEMENT D'UN TROUBLE DE PROLIFÉRATION CELLULAIRE DU SYSTÈME HÉMATOLOGIQUE
German Title of Invention:
N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE ZUR VERWENDUNG IN DER BEHANDLUNG EINER ZELLPROLIFERATIVEN KRANKHEIT DES HÄMATOLOGISCHEN SYSTEMS
SPC Number:

Dates

Filing date:
11/04/2013
Grant date:
19/06/2019
EP Publication Date:
28/06/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/06/2019
EP B1 Publication Date:
19/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/04/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/06/2019
 
 

Name:
Eisai R&D Management Co., Ltd.
Address:
6-10, Koishikawa-4-chome Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Name:
Epizyme Inc
Address:
400 Technology Square, 4th Floor, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
07/08/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
FANG, Frank
Address:
United States (US)

2

Name:
HUANG, Kuan-chun
Address:
United States (US)

3

Name:
KUNTZ, Kevin Wayne
Address:
United States (US)

4

Name:
CHOI, Hyeong Wook
Address:
United States (US)

5

Name:
MATHIEU, Steven
Address:
United States (US)

6

Name:
CHANDA, Arani
Address:
United States (US)

7

Name:
SANDERS, Kristen
Address:
United States (US)

Priority

Priority Number:
201261624215 P
Priority Date:
13/04/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/5377; A61P 35/00; A61P 35/02; C07D 405/12;

Publication

European Patent Bulletin

1

Issue number:
201925
Publication date:
19/06/2019
Description:
Grant (B1)

2

Issue number:
201930
Publication date:
24/07/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
14/08/2019 Outgoing Correspondence 1
07/08/2019 Power Of Attorney 1